Coronavirus vaccines: What we know about testing and availability
- The World Health Organization says that there are more than 40 research effort to develop a coronavirus vaccine.
- Two vaccine candidates are already undergoing human testing that could produce a coronavirus vaccine by as early as this fall.
- Business Insider compiled a list of all the coronavirus vaccine candidates that are undergoing research or human trials.
- Visit Business Insider's homepage for more stories.
The drug industry and health officials are now racing to respond to the coronavirus outbreak as cases of COVID-19 mount, and the World Health Organization has declared it a pandemic.
There are more than 40 ongoing research efforts across the globe to develop a coronavirus vaccine, according to the World Health Organization.
Two vaccine candidates, for instance, have already started human testing in record timing. But it will still take at least a year to determine if any vaccine works against this virus.
Here's is our list of the few vaccines that are undergoing human testing as well as other vaccine candidates that could become available in 2021.
Do you have a personal experience with the coronavirus you'd like to share? Or a tip on how your town or community is handling the pandemic? Please email email@example.com and tell us your story.
And get the latest coronavirus analysis and research from Business Insider Intelligence on how COVID-19 is impacting businesses.
The small biotech Moderna has leaped to the front of the race, with a vaccine candidate that's being tested in people.
Inovio Pharmaceuticals is the second company to start testing a coronavirus vaccine in the US.
The Chinese biotech CanSino Biological has started a Phase 1 safety trial for its experimental coronavirus vaccine.
Johnson & Johnson will scale up its manufacturing, committing more than $500 million to the project of developing a COVID-19 vaccine.
The French pharma giant Sanofi is taking several different approaches to developing a coronavirus vaccine.
Pfizer is partnering with BioNTech who's using a messenger RNA platform to quickly develop a candidate vaccine.
A German drugmaker called CureVac is aiming to start a Phase 1 trial as soon as June.
An experimental vaccine from the University of Queensland researchers is on track to start human testing in the second half of 2020.
A small Danish biotech called ExpreS2ion Biotechnologies aims to start human trials for a coronavirus vaccine within a year.
GSK and Vir Biotechnology are working on both medical treatments and coronavirus vaccines.
- I've had the new iPhone 14 for 2 weeks. I should've listened to Steve Jobs' daughter because I now regret buying it.
- China tells state banks to prepare for a massive dollar dump and yuan buying spree as Beijing's prior interventions have failed to stem its currency's worst year since 1994
- Here is a list of bank holidays in October 2022
- IISC joins hands with AIIMS Rishikesh to develop algorithm that can read brain scans to detect epilepsy
- Overlapping symptoms of dengue, Covid-19 confusing in many cases, say doctors
- Sterlite Technologies launches optical solution for 5G rollout
- NASA pushes back Artemis I Moon mission launch to November
- Auto sales jump in September: Maruti reports over a 100% jump in volumes